Huaren Pharmaceutical Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Huaren Pharmaceutical Co., Ltd. - overview
Established
1998
Location
Qingdao, Shandong, China
Primary Industry
Pharmaceuticals
About
Based in Qingdao, China and founded in 1998, Huaren Pharmaceutical Co. , Ltd. develops and produces non-PVC soft bags for therapeutic infusions.
Current Investors
HongTa Venture Capital
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.qdhuaren.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
Huaren Pharmaceutical Co., Ltd. - financials
| Fiscal Year Ended | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 404,644,208 | 561,751,877.2 | 866,889,465.5 | 916,247,088.6 | 1,105,508,438.8 | 1,247,822,316.1 | 1,310,491,011.3 | 1,381,354,313.1 | - | - | - |
| % Revenue Growth (YoY) | - | 38.8% | 54.3% | 5.7% | 20.7% | 12.9% | 5.0% | 5.4% | - | - | - |
| EBITDA (USD) | 122,710,513.4 | 160,932,063.7 | 254,424,769.3 | 207,112,930.2 | 220,117,864 | 242,455,288 | 269,921,643.1 | 225,588,152.3 | - | - | - |
| Operating Income (USD) | 89,538,455.3 | 116,292,941.7 | 164,663,895.1 | 102,440,951.6 | 82,717,956 | 91,814,842.1 | 113,705,698.2 | 81,219,635.8 | - | - | - |
| Operating Margin | 22.1% | 20.7% | 19.0% | 11.2% | 7.5% | 7.4% | 8.7% | 5.9% | - | - | - |
| % EBITDA Margin | 30.3% | 28.6% | 29.3% | 22.6% | 19.9% | 19.4% | 20.6% | 16.3% | - | - | - |
| NET Income (USD) | 87,560,917.7 | 97,973,535.8 | 121,519,386.9 | 56,153,985.3 | 22,176,647.2 | 22,406,832 | 39,043,327.3 | 37,461,176.6 | - | - | - |
| % Net Margin | 21.6% | 17.4% | 14.0% | 6.1% | 2.0% | 1.8% | 3.0% | 2.7% | - | - | - |
Huaren Pharmaceutical Co., Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Healstar | - | ||||||||
| Trade Sale | Completed | Hanhoo | - | ||||||||
| IPO | Completed | Huaren Pharmaceutical Co., Ltd. | - | ||||||||
| Unspecified Round | Completed | Huaren Pharmaceutical Co., Ltd. | - | ||||||||
| Series A | Completed | Huaren Pharmaceutical Co., Ltd. | - |
Displaying 1 - 5 of 6
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.